Mechanisms of host protection against pathogen-associated proteases in acute lung injury
急性肺损伤中宿主针对病原体相关蛋白酶的保护机制
基本信息
- 批准号:10898192
- 负责人:
- 金额:$ 56.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-01 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AblationAcute Lung InjuryAcute Respiratory Distress SyndromeAdmission activityAlpha GranuleAlveolarBacteriaBacterial InfectionsBacterial PneumoniaBiologyBlood PlateletsBlood capillariesCalibrationCathepsinsCell SurvivalCellsClinicalCritical CareDataElastasesEnvironmentEpithelial CellsExhibitsExtracellular MatrixGoalsHost DefenseHumanInfectionInflammationInflammatoryInflammatory ResponseInflammatory Response PathwayInjuryIntegration Host FactorsLeukocyte ElastaseLower respiratory tract structureLungLung infectionsManaged CareMediatingMetalloproteasesModelingMolecularMorbidity - disease rateMusMutationN-terminalNeutrophil ActivationOutcomePathogenicityPathway interactionsPatientsPeptide HydrolasesPlatelet ActivationPositioning AttributePredispositionProductionPropertyProtein SecretionProteolysisProteolytic ProcessingPseudomonasPseudomonas aeruginosaPseudomonas aeruginosa infectionPublishingPulmonary InflammationRNA InterferenceReporterRespiratory FailureRespiratory Tract InfectionsRoleSerine ProteaseSiteSourceStructure of parenchyma of lungSystemThrombospondin 1TranslatingType II Secretion System PathwayVirulenceVirusWorkantimicrobial drugconditional knockoutcytokineextracellularfungusimprovedin vivoindexinginhibitorintravital microscopylung injurymortalityneutralizing antibodyneutrophilpathogenpromote resiliencerational designrepairedrespiratoryresponsetargeted treatmenttissue injury
项目摘要
Project Summary/Abstract: The broad, long term objective is to identify host-protective mechanisms that
counter pathogen-initiated lung inflammation and injury. Many pathogens secrete proteases to cause direct
damage to the lung, but bacteria, fungi and viruses can also co-opt host proteases to increase pathogenicity
and promote lung injury. We have studied Pseudomonas aeruginosa (PA) as a model of infection-induced
injury to probe how a pathogen-encoded protease called Pseudomonas elastase LasB, a metalloprotease
released into the extracellular milieu by the PA type II secretion system, induces lung tissue damage and
secondary trigger of host-derived serine proteases such as neutrophil elastase (NE). We previously identified
thrombospondin-1 (TSP-1), a matricellular protein secreted by a variety of cells following injury that disarms
both pathogen-encoded LasB and host protease NE, to limit lung injury and inflammation. Key questions that
have arisen from this work is how an unregulated proteolytic environment drives excessive inflammatory
response and dysregulated repair following injury, and what are the host factors that calibrate this response in
the lung. Our preliminary findings suggest that a feed-forward neutrophilic inflammatory response occurs in the
proteolytic environment of PA infection through N-terminal processing of IL-36γ that is exaggerated in the
absence of TSP-1. Moreover, platelet TSP-1 appears protective against PA-induced lung injury, but the precise
mechanism related to TSP-1's role at the alveolar-capillary interface remains unknown. Furthermore, we show
that PA elastase activity in clinical strains confer excessive inflammation and injury in mice and is associated
with worse clinical outcomes when compared with non-elastase producers. Based upon these findings, we
propose the following aims utilizing genetically deficient mice, cell-specific conditional knockout systems, and
PA clinical respiratory isolates obtained from the ICU to (1) elucidate the mechanisms by which TSP-1
counters the hyperinflammatory response mediated by proteolytic processing of the pro-inflammatory cytokine
IL-36γ; (2) examine the contribution of TSP-1 and platelet TSP-1 in protection against alveolar barrier
disruption and stabilization of the early provisional matrix following lung injury; (3) determine whether PA ICU
respiratory isolates with elastolytic properties drive unwarranted inflammation and persistent tissue injury in the
susceptible host. A better understanding of host biology during severe respiratory infection could prove useful
in the rational design of targeted therapeutics against pathogen-derived proteases and deregulated host
inflammation as adjuncts to current antimicrobial agents and supportive pulmonary and critical care
management.
项目摘要/摘要:广泛的,长期的目标是确定宿主保护机制
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Fighting Bacterial Pathogens in the Lung: Platelets to the Rescue?
对抗肺部细菌病原体:血小板来拯救?
- DOI:10.1165/rcmb.2017-0349ed
- 发表时间:2018
- 期刊:
- 影响因子:6.4
- 作者:Olonisakin,TolaniF;Lee,JanetS
- 通讯作者:Lee,JanetS
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Janet Sojung Lee其他文献
Janet Sojung Lee的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Janet Sojung Lee', 18)}}的其他基金
Evaluation of alternative complement activity within an ARDS cohort
ARDS 队列中替代补体活性的评估
- 批准号:
10038565 - 财政年份:2020
- 资助金额:
$ 56.13万 - 项目类别:
Patient-Oriented Research in Acute Lung Injury and Host Defense in the ICU
ICU 中以患者为中心的急性肺损伤和宿主防御研究
- 批准号:
10814680 - 财政年份:2019
- 资助金额:
$ 56.13万 - 项目类别:
Patient-Oriented Research in Acute Lung Injury and Host Defense in the ICU
ICU 中以患者为中心的急性肺损伤和宿主防御研究
- 批准号:
10396528 - 财政年份:2019
- 资助金额:
$ 56.13万 - 项目类别:
Host control mechanisms against K. pneumoniae infection in the lungs
肺部肺炎克雷伯菌感染的宿主控制机制
- 批准号:
9532512 - 财政年份:2018
- 资助金额:
$ 56.13万 - 项目类别:
Infection as a risk factor for dementia: the role of CD36
感染作为痴呆症的危险因素:CD36 的作用
- 批准号:
10118704 - 财政年份:2018
- 资助金额:
$ 56.13万 - 项目类别:
Host control mechanisms against K. pneumoniae infection in the lungs
肺部肺炎克雷伯菌感染的宿主控制机制
- 批准号:
9913387 - 财政年份:2018
- 资助金额:
$ 56.13万 - 项目类别:
Mechanisms of host protection against pathogen-associated proteases in acute lung injury
急性肺损伤中宿主针对病原体相关蛋白酶的保护机制
- 批准号:
10231500 - 财政年份:2017
- 资助金额:
$ 56.13万 - 项目类别:
Mechanisms of host protection against pathogen-associated proteases in acute lung injury
急性肺损伤中宿主针对病原体相关蛋白酶的保护机制
- 批准号:
10478014 - 财政年份:2017
- 资助金额:
$ 56.13万 - 项目类别:
Enhancing Neutrophil Responses to Counter MDR Gram Negative Bacterial Pneumonia
增强中性粒细胞反应以对抗 MDR 革兰氏阴性细菌性肺炎
- 批准号:
8951695 - 财政年份:2015
- 资助金额:
$ 56.13万 - 项目类别:
Enhancing Neutrophil Responses to Counter MDR Gram Negative Bacterial Pneumonia
增强中性粒细胞反应以对抗 MDR 革兰氏阴性细菌性肺炎
- 批准号:
9089914 - 财政年份:2015
- 资助金额:
$ 56.13万 - 项目类别:
相似海外基金
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome
急性肺损伤和急性呼吸窘迫综合征的治疗
- 批准号:
8429041 - 财政年份:2011
- 资助金额:
$ 56.13万 - 项目类别:
Analysis of extravascular lung water dynamics and exhaustive evaluation of pulmonary epithelial metabolites to establish a novel therapeutic approach for acute lung injury/ acute respiratory distress syndrome
分析血管外肺水动力学和详尽评估肺上皮代谢物,以建立急性肺损伤/急性呼吸窘迫综合征的新治疗方法
- 批准号:
22592023 - 财政年份:2010
- 资助金额:
$ 56.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
OBSERVATIONAL STUDY OF ACUTE LUNG INJURY & ACUTE RESPIRATORY DISTRESS SYNDROME
急性肺损伤的观察性研究
- 批准号:
7603766 - 财政年份:2007
- 资助金额:
$ 56.13万 - 项目类别:
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome
急性肺损伤和急性呼吸窘迫综合征的治疗
- 批准号:
8602427 - 财政年份:2005
- 资助金额:
$ 56.13万 - 项目类别:
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome
急性肺损伤和急性呼吸窘迫综合征的治疗
- 批准号:
8602351 - 财政年份:2005
- 资助金额:
$ 56.13万 - 项目类别:
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome
急性肺损伤和急性呼吸窘迫综合征的治疗
- 批准号:
8654999 - 财政年份:2005
- 资助金额:
$ 56.13万 - 项目类别:
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome
急性肺损伤和急性呼吸窘迫综合征的治疗
- 批准号:
8844846 - 财政年份:2005
- 资助金额:
$ 56.13万 - 项目类别:
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome
急性肺损伤和急性呼吸窘迫综合征的治疗
- 批准号:
8328484 - 财政年份:2005
- 资助金额:
$ 56.13万 - 项目类别:
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome
急性肺损伤和急性呼吸窘迫综合征的治疗
- 批准号:
8328493 - 财政年份:2005
- 资助金额:
$ 56.13万 - 项目类别:
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome
急性肺损伤和急性呼吸窘迫综合征的治疗
- 批准号:
8020428 - 财政年份:2005
- 资助金额:
$ 56.13万 - 项目类别:














{{item.name}}会员




